There was a decrease in cell activity in the disease group (p < 0.01 vs. CTL), and the cell activity significantly increased in the Rapa group (p < 0.01 vs. AD), suggesting that inhibition of mTOR signaling pathway could protect Aβ25-35-induced SH-SY5Y cells. This evidence concerns the gene TRERF1 and Alzheimer disease.